Antibody levels after COVID-19 vaccination inversely linked to body weight
May 23, 2022
An inverse correlation was sustained for up to six months following two doses of BNT162b2 (Pfizer–BioNTech) in a small cohort of healthy young and middle-aged adults.
FDA approves updated Novavax COVID-19 vaccine
Oct 04, 2023
The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.
mRNA Vaccine more effective booster to ChAdOx1 nCoV-19
Oct 22, 2021
“Our study shows a greater risk reduction for people who received an mRNA vaccine after having received a first dose of a vector-based, as compared to people having received the vector-based vaccine...
FDA could approve Pfizer booster shots for all adults this week
Nov 17, 2021
More than 30 million Americans already have gotten booster shots.
FDA questions strength of Johnson & Johnson booster shot data
Oct 13, 2021
The agency says a key test used by the company to measure immune response from booster shot six months after the original shot was likely not sensitive enough.
Immune response may vary with choice of COVID-19 booster
Dec 16, 2021
All seven vaccines tested boosted immunity following two doses of ChAdOx1 nCoV-19; six of seven did so following two doses of BNT162b2.
FDA advisers say next round of COVID-19 booster shots should target an XBB Variant
Jun 15, 2023
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.
Risk for myocarditis low after third dose of BNT162b2 vaccine
Mar 24, 2022
The incidence of myocarditis among young men estimated to be 6.43 and 11.25 per 100,000 vaccines in the week to two weeks after third dose..
U.S. begins targeted vaccine rollout against monkeypox
Jun 29, 2022
HHS is rapidly expanding access to hundreds of thousands of doses of the Jynneos vaccine.
First needle-free COVID-19 vaccines receive approval in India, China
Sep 07, 2022
Nasal and inhaled vaccines place doses directly where the virus enters the body, such as in the nose or mouth.